Effect of cyclothiazide on binding properties of AMPA-type glutamate receptors: Lack of competition between cyclothiazide and GYKI 52466

Molecular Pharmacology

Volumn 49, Issue 1, 1996, Pages 123-131

  Kessler, Markus ^a   Arai, Amy ^a   Quan, Alex ^a   Lynch, Gary ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; BENZODIAZEPINE DERIVATIVE; CYCLOTHIAZIDE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; THIOCYANATE; TRITIUM;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BRAIN MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION;

ANIMALS; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; BENZOTHIADIAZINES; BINDING, COMPETITIVE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; TRITIUM;

EID: 0030058193     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Yamada, K. A., and C.-M. Tang. Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents. J. Neurosci. 13:3904-3915 (1993).
2. Wong, L. A., and M. L. Mayer. Differential modulation by cyclothiazide and concanavalin A of desensitization at native AMPA- and kainate-preferring glutamate receptors. Mol. Pharmacol. 44:504-510 (1993).
3. Trussell, L. O., S. Zhang, and I. M. Raman. Desensitization of AMPA receptors upon multiquantal neurotransmitter release. Neuron 10:1185-1196 (1993).
4. Partin, K. M., D. K. Patneau, and M. L. Mayer. Cyclothiazide differentially modulates desensitization of AMPA receptor splice variants. Mol. Pharmacol. 46:129-138 (1994).
5. Larson, J., T.-T. Le, R. A. Hall, and G. Lynch. Effects of cyclothiazide on synaptic responses in slices of adult and neonatal hippocampus. Neuroreport 5:389-392 (1994).
6. Granger, R., U. Staubli, M. Davis, Y. Perez, L. Nilsson, G. A. Rogers, and G. Lynch. A drug that facilitates glutamatergic transmission reduces exploratory activity and improves performance in a learning dependent task. Synapse 15:326-329 (1993).
7. Granger, E., S. Deadwyler, M. Davis, B. Moskovitz, G. Rogers, and G. Lynch. Facilitation of glutamate receptors reverses an age-associated memory impairment in rats. Synapse, in press.
8. Staubli, U., G. Rogers, and G. Lynch. Facilitation of glutamate receptors enhances memory. Proc. Natl. Acad Sci. USA 91:777-781 (1994).
9. Staubli, U., Y. Perez, F. Xu, G. Rogers, M. Ingvar, S. Stone-Elander, and G. Lynch. Centrally active modulators of glutamate (AMPA) receptors facilitate the induction of LTP in vivo. Proc. Natl. Acad. Sci. USA 91:11158-11162 (1994).
10. Shors, T. J., R. J. Servatius, R. F. Thompson, G. Rogers, and G. Lynch. Enhanced glutamatergic neurotransmission facilitates classical conditioning in the freely-moving rat. Neurosci. Lett. 186:153-156 (1995).
11. Larson, J., T. Lieu, V Petchpradub, B. LeDuc, H. Ngo, G. A. Rogers, and G. Lynch. Facilitation of olfactory learning by a modulator of AMPA receptors. J. Neurosci., in press.
12. 3H]AMPA binding to rat brain membranes: evidence that AMPA receptor desensitization increases agonist affinity. Brain Res. 628:345-348 (1993).
13. Hall, R A., G. Massicotte, M. Kessler, M. Baudry, and G. Lynch. Thiocyanate equally increases affinity for two AMPA receptor states. Mol. Pharmacol. 43:459-464 (1993).
14. Bowie, D., and T. G. Smart. Thiocyanate ions selectively antagonize AMPA-evoked responses in Xenopus laevis oocytes microinjected with rat brain mRNA. Br. J. Pharmacol. 109:779-787 (1993).
15. Arai, A., J. Silberg, M. Kessler, and G. Lynch. Effect of thiocyanate on AMPA receptor mediated responses in excised patches and hippocampal slices. Neuroscience 66:815-827 (1995).
16. Palmer, A. J., and D. Lodge. Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI 53655. Eur. J. Pharmacol. 244:193-194 (1993).
17. Zorumski, C. F., K. A. Yamada, M. T. Price, and J. W. Olney. A benzodiazepine recognition site associated with the nonNMDA glutamate receptor. Neuron 10:61-67 (1993).
18. Donevan, S. D., and M. A. Rogawski. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron 10:51-59 (1993).
19. Sharp, R. L., P. C. May, N. G. Mayne, Y. M. Snyder, and J. P. Burnett. Cyclothiazide potentiates agonist responses at human AMPA/kainate receptors expressed in oocytes. Eur. J. Pharmacol. 266:R1-R2 (1994).
20. Tarnawa, I., P. Molnar, L Gaal, and F. Andrasi. Inhibition of hippocampal field potentials by GYKI 52466 in vitro and in vivo. Acta Physiol. Hung. 79:163-169 (1992).
21. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254 (1976).
22. Hall, R. A., M. Kessler, and G. Lynch. Kainate binding to the AMPA receptor in rat brain. Neurochem. Res. 19:777-782 (1994).
23. 3H]CNQX binds with equal affinity to two agonist states of quisqualate receptors. Biochem. Pharmacol. 38:3207-3212 (1989).
24. 3H]GYKI 53405 to Xenopus brain membranes. Neuroreport 5:93-94 (1993).
25. Vyklicky, L , Jr , D. K. Patneau, and M L. Mayer. Modulation of excitatory synaptic transmission by drugs that reduce desensitization at AMPA/ kainate receptors. Neuron 7:971-984 (1991).
26. Ambros-Ingerson, J., and G. Lynch. Channel gating kinetics and synaptic efficacy. a hypothesis of LTP expression. Proc. Natl. Acad. Sci. USA 90:7903-7907 (1993).
27. Jonas, P., and B. Sakmann. Glutamate receptor channels in isolated patches from CA1 and CA3 pyramidal cells of rat hippocampal slices. J. Physiol. 455:143-171 (1992).
28. Trussell, L. O., and G. D. Fischbach. Glutamate receptor desensitization and its role in synaptic transmission. Neuron 3:209-218 (1989).
29. Arai, A., M. Kessler, P. Xiao, J. Ambros-Ingerson, G. Rogers, and G. Lynch. A centrally active drug that modulates AMPA receptor gated currents. Brain Res. 638:343-346 (1994).
30. Desai, M. A., J. P. Burnett, P. L. Ornstein, and D. D. Schoepp. Cyclothiazide acts at a site on the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists. J. Pharmacol. Exp Ther. 272:38-43 (1995).